Quality of Life after Colorectal Cancer Surgery in Patients from University Clinical Hospital Mostar, Bosnia and Herzegovina by Zoran Trninić et al.
Coll. Antropol. 33 (2009) Suppl. 2: 1–5
Original scientific paper
Quality of Life after Colorectal Cancer Surgery in
Patients from University Clinical Hospital Mostar,
Bosnia and Herzegovina
Zoran Trnini}1, Ana Vida~ak2, Jasna Vrhovac3, Bo`o Petrov4,5 and Violeta [etka1
1 Surgery Clinic, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
2 Department of Physical Medicine and Rehabilitation, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
3 School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina
4 Department of Psychiatry, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
5 Department of Medical Statistics, School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina
A B S T R A C T
Quality of life (QoL) has become an important outcome measure for patients with cancer, but results from popula-
tion-based studies are infrequently published. The objective of this study was to asses QoL in patients who underwent the
colorectal cancer (CRC) surgery and to compare it to the QoL of general population. The patients who were admitted
from January 2004 until May 2006 at the Department of Gastrointestinal Surgery at the Clinical Hospital Mostar,
Bosnia and Herzegovina were divided in three groups: group of CRC patients who had received surgery and as a result
of surgical treatment have colostomy, group of CRC patients who had received surgery in the same period and don’t have
colostomy and the third group that consisted of controls. QLQ-C30 and QLQ-CR38 questionnaires by the European Or-
ganization for Cancer Research and Treatment (EORTC) were used. A total of 67 patients were included in this study,
supplemented by the thirty healthy examinees. Healthy group had significantly better results in physical functioning
compared with colorectal cancer patients and better results in cognitive and social functioning. Also, they reported symp-
toms of diarrhea and constipation less frequently than the group with colostomy and. The group with colostomy had
poorer results in emotional functioning than the group without colostomy, and also reported significantly poorer results
for domain »body image«. Healthy group showed better results in sexual enjoinment than the patient with colorectal can-
cer. Patients without colostomy reported more micturition and defecation problems and female sexual problems com-
pared to the healthy group. Generally we found that healthy population had better results than the CRC patients, while
the patients with stoma had worse results than the nonstoma patients. The results presented here suggest that psycholog-
ical treatment should be an integral part of the CRC treatment plan.
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Introduction
Colorectal cancer is the second leading cause of can-
cer-related mortality and the fourth most prevalent ma-
lignant disease. It affects men and women almost equa-
lly. Almost one million new incident cases and 250,000
deaths occur worldwide each year1. Survival rates have
increased throughout the last decades because of earlier
diagnosis, improved diagnostic test, introduction of adju-
vant therapy, and advances in the treatment of meta-
static disease. Approximately 80% of patients now sur-
vive the first year after diagnosis and approximately 62%
survive 5 years and more2. According to Epidemiology
Service of the Croatian Institute for Public Health each
year about 3000 new cases are registered3. Postoperative
outcome has traditionally been assessed as survival or
improvement of disease-related symptoms. These mea-
sures place no emphasis on the patient’s overall percep-
tion of the impact of an operation on subjectively experi-
enced distress or wellbeing. Health-related quality of life
(QoL) measures have therefore been developed and used
increasingly to measure the effectiveness of therapeutic
interventions. In gastroenterology surgery these mea-
sure are variable. It is also difficult to distinguish be-
1
Received for publication March 31, 2009
tween the effects of the disease itself and the therapeutic
intervention on the health-related QoL4. The term QoL
refers to a multidimensional concept, which includes, at
least, the dimension of physical, emotional, and social
functioning. In addition, assessment of QoL in patients
with cancer may improve our understanding of how can-
cer and therapy influence patients’ lives and how to
adapt treatment strategies5. Colorectal cancer and its
treatment can have an adverse effect on social function-
ing, including work and productive life; relationships
with friends, relatives, and partners; and other social ac-
tivities and interests6. Patients with colorectal cancer,
both stoma and nonstoma patients, are troubled by fre-
quent or irregular bowel movements, diarrhea, flatu-
lence, and fatigue, and often have to follow dietary re-
strictions7,8. QoL measures are critical to the evaluation
of the new cancer treatment either surgical or nonsur-
gical. Each year more and more studies and trials are
published and EORTC QLQ-C30 and CR38 are most fre-
quently used instruments9. Recent studies were con-
ducted to determine value of population based testing
and to compare QoL values between healthy population
and colorectal cancer patients. No such investigations
were reported in our region yet6,10.
The aim of this study is to compare QoL measured by
EORTC QLQ-C30 and QLQ-CR38 questionnaires be-
tween stoma and nonstoma CRC patients and compare
both groups with healthy population sample.
Subjects and Methods
This study was conducted from January 2004 until
May 2006 in the Department of Gastrointestinal Surgery
at the Clinical Hospital Mostar, Bosnia and Herzegovina.
It was based on the two measurements related to the
quality of life in colorectal patients: measurement using
QLQ C-30 questionnaire and QLQ CR-38 questionnaire.
Quality of life measurement
Quality of life was measured using two instruments:
the European Organization for Research and Treatment
for Cancer (EORTC) QLQ C-30 questionnaire (version
3.0) and the EORTC colorectal module QLQ C-38 ques-
tionnaire. First questionnaire can be applied to all pa-
tients with malignant tumors, while the QLQ-CR38 is only
intended for evaluation of colorectal cancer patients11.
Data analysis for EORTC instruments was carried
out using the official scoring procedures for the QLQ-C30
and QLQ-CR38. The QLQ-C30 is composed of both multi-
-item scales and single-item measures. These include five
functional scales (physical, role, emotional, cognitive and
social functioning), three symptom scales, a global health
status/QoL scale, and six single items (fatigue, nausea
and vomiting, pain, dispnea, insomnia, loss of appetite,
constipation, diarrhea and financial difficulties). All of
the scales and single-item measures range in score from
0 to 100. A high scale score represents a higher response
level. Thus a high score for a functional scale represents
a high/healthy level of functioning, a high score for the
global health status/QoL represents a high QoL, but a
high score for a symptom scale/item represents a high
level of symptomatology/problems12,13.
The EORTC QLQ-CR38 module comprises 38 ques-
tions assessing disease symptoms, side effects of treat-
ment (sphincter-saving resection, rectum extirpation, ra-
diotherapy and chemotherapy) and four functional scales:
body image, sexual enjoyment, sexual functioning and
future perspective. All patients complete 19 questions,
while the remaining questions are completed by sub sam-
ples of patients (men or women; patients with or without
a stoma)14.
Examinees
Examinees were divided into three groups: (i) group
of colorectal cancer patients who had underwent surgery
from January 2004 until January 2005 and as a result of
surgical treatment have colostomy, (ii) group of colo-
rectal cancer patients who had received surgery in the
same period and don’t have colostomy and (iii) the third
group, which consisted of healthy people who were cho-
sen by random sampling. Ninety-one patients with colo-
rectal carcinoma were approached for this study. The pa-
tients were asked for participating in the study.
The first measurement (questionnaire QLQ-C30) which
was conducted in April 2005: four (4.4%) patients refused
to participate; eleven (12.1%) patients were excluded
from study because of missing data, nine (9.9%) patients
died. Of the remaining 67 (73.6%) patients, 35 (38.5%)
patients were with colostomy and 32 (35.2%) patients
without colostomy (Figure 1). The sample thus consisted
of 34 men and 33 women. Men/women ratio in the cancer
group with colostomy was 18/17, and that in the cancer
group without colostomy was 16/16. Mean age for the
cancer group with colostomy was 64 years (SD=12.9),
and that of the cancer group without colostomy was 61
years (SD=12.7). In the group of healthy people were 30
examinees. Men/women ratio in this group was 15/15,
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Fig. 1. Flow of the groups of examinees in the study.
and mean age was 60 years (SD=12.2). The differences
in men/women ratio and in age between these three
groups were not significant.
Second measurement (QLQ-CR38) was conducted in
April 2006, on the same sample that filled out the first
questionnaire. A total of three (8.6%) patients were un-
reachable, two (5.7%) patients refused to participate, and
five (14.3%) patients died. In cancer group without colos-
tomy three (9.4%) patients died. Fifty four colorectal can-
cer patients and 30 examinees from healthy group partic-
ipated in research with questionnaire QLQ-CR38. Of the
54 patients, 25 (29.8%) patients were with colostomy and
29 (34.5%) patients without colostomy (Figure 1). Men/
women ratio in the cancer group with colostomy was
11/14, and that in the cancer group without colostomy
was 14/15. Men/women ratio in the healthy group was
15/14. Mean age for the cancer group with colostomy was
65 years (SD=12.5), and that of the cancer group with-
out colostomy was 60 years (SD=12.3). Mean age of the
healthy group was 61 years (SD=12.1). The differences
in men/women ratio and in age between these three
groups were not significant.
Statistical analysis
Data were reported as means and standard deviations
(SD). Differences between more than two groups of exa-
minees were compared using the Kruskal-Wallis test.
Data between two groups of examinees were compared
with Mann-Whitney U test. For all analyses, p<0.05 was
considered significant. Data were analyzed using SPSS,
version 13.015.
Results
Comparing the three groups, significantly better re-
sults in physical functioning were observed for the heal-
thy group when compared with two other groups of colo-
rectal cancer patients, the group with colostomy (p=0.029)
and the group without colostomy (p=0.032). Financial
difficulties were significantly more expressed in the group
with colostomy than the other two groups, healthy group
(p=0.003) and group without colostomy (p=0.001). The
instrument QLQ-C30 showed significant difference in
the level of symptoms of diarrhea (p=0.003) and consti-
pation (p=0.013) between these three groups. Intra group
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TABLE 1
FUNCTIONAL AND SYMPTOM SCALES (MEAN±SD) MEASURED WITH THE EUROPEAN ORGANIZATION FOR RESEARCH





With colostomy Without colostomy Healthy group
Global health 69.01 (21.81) 67.38 (22.98) 67.22 (25.79) 0.962
Physical functioning 69.37 (22.70) 70.09 (21.77) 81.33 (18.39)§ 0.046
Role functioning 76.56 (22.34) 75.71 (21.13) 82.77 (23.35) 0.223
Emotional functioning 69.27 (21.10) 75.95 (30.30)† 75.00 (17.64) 0.093
Cognitive functioning 79.16 (16.39)¶ 82.85 (22.31) 86.11 (23.60) 0.072
Social functioning 74.47 (25.03)£ 83.33 (20.61) 88.88 (18.22) 0.061
Financial functioning 56.25 (27.35)‡ 84.76 (21.90) 77.77 (28.13) 0.001
Pain 22.91 (17.32) 22.38 (23.89) 25.00 (22.63) 0.838
Dyspnoea 15.62 (16.90) 13.33 (21.69) 17.77 (20.96) 0.499
Fatigue 36.80 (16.31) 36.82 (22.02) 34.07 (21.62) 0.561
Insomnia 28.12 (24.11) 21.90 (24.17) 28.88 (29.98) 0.513
Appetite loss 15.62 (18.90) 15.23 (18.68) 12.22 (20.49) 0.583
Nausea and vomiting 10.93 (13.78) 7.14 (14.73) 7.22 (12.13) 0.227
Constipation 25.00 (25.40)¥ 18.09 (27.22) 7.77 (14.33) 0.013
Diarrhea 23.95 (19.37) 23.80 (25.01) 8.88 (19.44)II 0.003
* Abbreviations: SD – standard deviation; ** Kruskal-Wallis test
† Significant difference from the group with colostoma (p=0.048) (Mann-Whitney U-test)
‡ Significant difference from the group with colostoma (p=0.001) and from the healthy group (p=0.003) (Mann-Whitney U-test)
§ Significant difference from the group with colostoma (p=0.029) and from the group without colostoma (p=0.032)
(Mann-Whitney U-test)
II Significant difference from the group with colostoma (p=0.001) and from the group without colostoma (p=0.004)
(Mann-Whitney U-test)
¶ Significant difference from the healthy group (p=0.017) (Mann-Whitney U-test)
£ Significant difference from the healthy group (p=0.020) (Mann-Whitney U-test)
¥ Significant difference from the healthy group (p=0.003) (Mann-Whitney U-test)
analysis showed that the group with colostomy had more
expressed symptoms of diarrhea (p=0.001) and constipa-
tion (p=0.003) when compared with the healthy group.
The group without colostomy in comparison to healthy
group had more expressed symptoms of diarrhea (p=0.004).
The group with colostomy showed poorer results in emo-
tional functioning (p=0.048) when compared with the
group without colostomy. The group with colostomy had
also poorer results than healthy group in cognitive func-
tioning (p=0.017) and in social functioning (p=0.020)
(Table 1).
The group with colostomy also showed significantly
poorer results for the domain »body image« than healthy
group (p=0.001) and the group without colostomy (p=
0.022). In sexual enjoyment lesser results were observed
for the group with colostomy (p=0.004) and for the group
without colostomy (p=0.029) when compared with the
healthy group. In the group without colostomy there
were more expressed micturition problems (p=0.035)
than in the healthy group. The disease-specific tool QLQ-
-CR38 also showed frequent female sexual problems in
the group without colostomy (p=0.048) when compared
to the healthy group (Table 2).
Defecation problems where more expressed in the
group without colostomy (12.81±7.09) compared to heal-
thy group (5.24±6.89) (p<0.001).
Discussion
This is the first study of QoL of CRC patients in the
region and the results showed that subjects from general
population have better results of QLQ tests than CRC
patients and those patients with colostomy had worse re-
sults than patients without colostomy. That was expected
and is consistent with other investigations16–19. An expla-
nation for the small difference in overall QoL and gen-
eral health between CRC patients and general popula-
tion may be that the patients been treated for malignancy
expect a different concept of subjective well being com-
pared to healthy individuals and as the result reports
more optimistic assessment of QoL6. Further this can be
result of small size of the groups in this study specially
the general population group. This emphasizes the need
for further investigation on CRC patients and general
population such as those in Germany and Norway to ex-
clude regional specificities20,21.
Financial difficulties expressed in colostomy group
are result of the medical insurance policy. Only a part of
the stoma care products’ costs was recognized by the in-
surance found at the time of the study. Unlike some other
studies22 we have found that colostomy group showed
worse result in emotional functioning, »body image« and
sexual enjoyment than the group without colostomy.
This emphasizes that stoma therapeutist and psycholo-
gist should be included in treatment of CRC patients23.
Gastrointestinal concerns a constant in our as in all simi-
lar studies24. Healthy group had les expressed symptoms
of diarrhea and constipation than the group with colos-
tomy and les express symptoms of diarrhea than the
group without colostomy. Further investigations should
be perform in order to assess how will patients’ educa-
tion and including the patient in the process of decision
making influence QoL and overall outcome.
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TABLE 2
FUNCTIONAL AND SYMPTOM SCALES (MEAN±SD) MEASURED WITH THE EUROPEAN ORGANIZATION FOR RESEARCH





With colostomy Without colostomy Healthy group
Body image 79.11 (20.61)† 91.57 (10.14) 100.00 (10.53) 0.001
Future perspective 74.67 (27.69) 77.01 (25.36) 72.41 (23.69) 0.671
Sexual functioning 28.67 (24.30) 27.01 (23.32) 29.88 (30.33) 0.962
Sexual enjoyment 38.46 (18.49) 44.44 (20.57) 64.44 (19.79)‡ 0.005
Micturition problems 14.52 (15.30) 22.96 (15.97) 6.67 (10.95)§ 0.072
Symptoms in the area of
gastro-intestinal tract
19.44 (15.59) 19.31 (11.45) 15.11 (13.09) 0.282
Male sexual problems 33.33 (28.87) 18.51 (19.44) 10.42 (23.47) 0.176
Female sexual problems 19.44 (16.39) 30.00 (18.26)¶ 7.14 (8.91) 0.069
Weight loss 6.67 (13.61) 4.59 (11.69) 4.44 (14.47) 0.611
* Abbreviations: SD – standard deviation; ** Kruskal-Wallis test
† Significant difference from the group without colostoma (p=0.022) and from the healthy group (p=0.001) (Mann-Whitney U-test)
‡ Significant difference from the group with colostoma (p=0.004) and from the group without colostoma (p=0.029)
(Mann-Whitney U-test)
§ Significant difference from the group without colostoma (p=0.035) (Mann-Whitney U-test)
II Significant difference from the healthy group (p=0.008) (Mann-Whitney U-test)
¶ Significant difference from the healthy group (p=0.048) (Mann-Whitney U-test)
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KVALITETA @IVOTA BOLESNIKA OPERIRANIH RADI KOLOREKTALNOG KARCINOMA U
KLINI^KOJ BOLNICI MOSTAR
S A @ E T A K
Kvaliteta `ivota (QoL) je postala va`no mjerilo ishoda kod pacijenata s malignom bolesti, ali nema mnogo rezultata
studija populacijskih studija. Cilj na{eg istra`ivanja bio je utvrditi QoL bolesnika operiranih zbog kolorektalnog carci-
noma (CRC), usporedba s QoL op}e populacije, kao i usporedba QoL bolesnika sa stomom i bez stome. Ovo istra`ivanje
provedeno je od sije~nja 2004. do svibnja 2006. godine na odjelu abdominalne kirurgije Klini~ke bolnice Mostar, Bosna i
Hercegovina. Istra`ivanje se temelji na dva mjerenja QoL bolesnicima od CRC: mjerenje je izvedeno upitnicima za
kvalitetu `ivota Europske organizacije za istra`ivanje i lije~enje karcinoma (EORTC) QLQ-C30 i QLQ-CR38. Ispitanici
su bili podijeljeni u tri grupe: grupu bolesnika operiranih radi CRC koji imaju kolostomu kao posljedicu operativnog
lije~enja, grupu bolesnika operiranih radi CRC bez kolostome i tre}u grupu u kojoj su bili zdravi ljudi izabrani metodom
slu~ajnog odabira. U ovo istra`ivanje je uklju~eno {ezdeset sedam bolesnika i trideset zdravih ispitanika. Svi su bili
ispitani s upitnikom QLQ-C30. Testiranje s upitnikom QLQ-CR 38 je izvedeno kasnije i trinaest bolesnika je isklju~eno
radi raznih razloga. Zdrava grupa je pokazala zna~ajno bolje rezultate u fizi~kom funkcioniranju u odnosu na bolesnike
i bolje rezultate u kognitivnom i socijalnom funkcioniranju od grupe s kolostomom. Financijske pote{ko}e su bile izra-
`enije u grupi s kolostomom nego kod ostalih. Zdravi su imali manje problema s dijarejom i opstipacijom nego bolesnici
s kolostomom i manje problema s dijarejom nego bolesnici bez kolostome. Bolesnici s kolostomom pokazali su lo{ije
rezultate u emotivnom funkcioniranju od onih bez kolostome. Koriste}i specifi~ni test na{li smo da grupa s kolostomom
pokazuje zna~ajno slabije rezultate za domenu »tjelesni izgled« od zdravih i grupe bez kolostome. Zdrava grupa je
pokazala bolje rezultate u spolnom zadovoljstvu nego bolesnici. Bolesnici s kolostomom su imali vi{e problema s mokre-
njem i stolicom kao i `enskih spolnih problema nego zdrava grupa. Sumarno, rezultati ukazuju na to da zdrava popu-
lacija ima bolje rezultate nego pacijenti od CRC te da pacijenti sa stomom imaju lo{ije rezultate nego oni bez stome.
Male razlike mogu biti posljedica smanjenog o~ekivanog QoL kod pacijenata s CRC. Lo{i rezultati pacijenata sa stomom
u financijskom, emocionalnom i spolnom funkcioniranju ukazuju na potrebu uklju~enja psihologa i stoma terapeuta u
lije~enje bolesnika s CRC.
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